| Formatted contents note |
Ch 1. Vaccines and Vaccination in Historical Perspective / Myron M. Levine, Rosanna Lagos -- Ch.2 The Traditional Vaccines: An Overview / Gordon L. Ada -- Ch.3 An Overview of Biotechnology as Applied to Vaccine Development / Graeme C. Woodrow -- Ch.4 Initial Clinical Evaluation of New Vaccine Candidates: Phase 1 and 2 Clinical Trials of Safety, Immunogenicity, and Preliminary Efficacy / Carol O. Tacket, Tacket J. Mattheis, Margaret Baker Rennels -- Ch.5 Long-Term Evaluation of Vaccine Protection: Methodological Issues for Phase 3 Trials and Phase 4 Studies / John D. Clemens, Abdollah Naficy, Malla R. Rao -- Ch.6 Economic Analyses of Vaccines and Vaccination Programs: Evaluating the Economic Rationale for Immunization / Orin S. Levine, Benjamin Schwartz -- Ch.7 Reaping the Benefits: Getting Vaccines to Those Who Need Them / J. W. Lee, Bruce Aylward, Harry F. Hull [et al.] -- Ch.8 Progress and Challenges in Modern Vaccinology: An Immunologist's Perspective / Gustav J. V. Nossalv -- Ch.9 The Eradication of Vaccine-Preventable Diseases / William Foege -- Ch.10 Recent Advances in Immunology: Impact on Vaccine Development / Marcelo B. Sztein, Graham F. Mitchell -- Ch.11 Computer Prediction of T-Cell Epitopes / Anne S. De Groot, Gabriel E. Meister, James L. Cornette [et al.] -- Ch.12 Identification of B- and T-Cell Epitopes Through Structural Characterization and Peptide Technology / Juan A. Cooper, Allan J. Saul -- Ch.13 The Gastrointestinal Mucosal Immune System / Stephen P. James -- Ch.14 Adjuvants for the Future / Robert Edelman -- Ch.15 Proteosomes for Improved Nasal, Oral, or Injectable Vaccines / George H. Lowell -- Ch.16 Liposomes as Adjuvants for Vaccines / Carl R. Alving 207 17 Prospects for the Development of New and Improved Vaccines Through the Use of Microencapsulation Technology / Derek T. O'Hagan -- Ch.18 Antigen Cochleate Preparations for Oral and Systemic Vaccination / Raphael J. Mannino, Susan Gould-Fogerite -- Ch.19 Ty Virus-like Particles as an Antigen Delivery System / Guy T. Layton -- Ch. 20 Immunopotentiating Reconstituted Influenza Virosomal Vaccine Delivery System / Reinhard Gluck, Stanley J. Cryz, Jr. -- Ch. 21 Mutant Pertussis and Escherichia coli Heat-Liable Toxins as Adjuvants for Enhancing Local and Systemic Immune Responses to Coadministered, Nonliving Antigens / Gillian Douce, Gordon Dougan, MariaGrazia Pizza [et al.] -- Ch. 22 Oral Vaccine Production in the Edible Tissues of Transgenic Plants / Charles J. Arntzen, Hugh S. Mason -- Ch.23 DNA-Based Vaccines: Extending the Technology / Stephen Albert Johnston, Kathryn F. Sykes, Michael A. Barry -- Ch.24 Vaccination Against Influenza with Plasmid DNA: Cross-Strain and Homologous Protection / John J. Donnelly, Jeffrey B. Ulmer, Margaret A. Liu -- Ch. 25 Vaccinia Virus as a Live Vector for Expression of Immunogens / Charles Flexner, Bernard Moss -- Ch.26 Attenuated Poliovirus as Live Vector / Matthias Gromeier, Hui-Hua Lu, Steffen Mueller [et al.] 315 27 Attenuated Salmonella as a Live Vector for Expression of Foreign Antigens 331 i Expressing Bacterial Antigens / S. N. Chatfield, Gordon Dougan 331 ii Carrying Viral Antigens / Fiorian Schodel 343 iii Salmonella Expressing Protozoal Antigens / Myron M. Levine, James E. Galen, Marcelo B. Sztein [et al.] -- Ch. 28 BCG as a Recombinant Vaccine Vector / Glenn J. Fennelly, William R. Jacobs, Jr., Barry R. Bloom -- Ch.29 Attenuated Vibrio cholerae as a Live Vector for Expression of Foreign Antigens / Joan R. Butterton, Stephen B. Calderwood -- Ch.30 New and Improved Vaccines Against Pertussis / Erik L. Hewlett, James D. Cherry -- Ch.31 New and Improved Vaccines Against Diphtheria and Tetanus / Rino Rappuoli -- Ch.32 Progress in Development of New Attenuated Strains of Salmonella typhi as Live Oral Vaccines Against Typhoid Fever / Myron M. Levine, Carol O. Tacket, James E. Galen [et al.] -- Ch. 33 New and Improved Vaccines Against Cholera 447 i Attenuated Vibrio cholerae O1 and O139 Strains as Live Oral Cholera Vaccines / James B. Kaper, Carol O. Tacket, Myron M. Levine 447 ii Oral B Subunit Killed Whole-Cell Cholera Vaccine / Jan Holmgren, Marianne Jertborn, Ann-Mari L. Svennerholm -- Ch. 34 New and Improved Vaccines Against Meningococcal Disease / Wendell D. Zollinger -- Ch.35 Epidemiological Impact of Conjugate Vaccines on Invasive Disease Caused by Haemophilus influenzae Type b / Jay D. Wenger, Robert Booy, Paul T. Heath [et al.] -- Ch. 36 Conjugate Vaccines Against Streptococcus pneumoniae / David L. Klein, Ronald W. Ellis -- Ch. 37 Vaccine Development for Rickettsial Infections: Rocky Mountain Spotted Fever, Epidemic Typhus, and Scrub Typhus / Kimberly W. Schuenke, David H. Walker -- Ch.38 New and Improved Vaccines Against Influenza / Mary Lou Clements, Ina Stephens -- Ch. 39 New Vaccines Against Hepatitis A / Jack T. Stapleton, Stanley M. Lemon -- Ch.40 New and Improved Vaccines for Dengue, Japanese Encephalitis, and Yellow Fever Viruses / Niranjan Kanesa-thasan, Robert Putnak, Charles H. Hoke, Jr. -- Ch. 41 Improved Vaccines Against Rabies / Zhen Fang Fu, Bernhard Dietzschold, Stanley A. Plotkin [et al.] -- Ch. 42 Combination Vaccines for Routine Infant Immunization: Prospects, Progress, and Dilemmas / Carole Heilman, N. Regina Rabinovich -- Ch. 43 New Vaccines Against Tuberculosis / Douglas Young, Uli Fruth 631 44 Live Attenuated Varicella Vaccines / Michiaki Takahashi, Anne A. Gershon 647 -- Ch. Vaccines Against Rotavirus / Paul A. Offit, H. Fred Clark, Albert Z. Kapikian -- Ch. 46 Experimental HIV-1 Vaccines / Mary Lou Clements -- Ch. 47 Vaccines Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3 / James E. Crowe, Jr., Peter L. Collins, Robert M. Chanock [et al.] -- Ch. 48 Herpes Simplex Vaccines / Richard J. Whitley 727 49 Vaccines Against Arenaviruses and Filoviruses / J. Christopher S. Clegg, Anthony Sanchez -- Ch. 50 Vaccines Against Papillomavirus Infections / Robert W. Tindle, Ian H. Frazer -- Ch. 51 Vaccines Against Streptococcus pyogenes Infections / Debra E. Bessen, Vincent A. Fischetti -- Ch.52 O-Specific Polysaccharide-Protein Conjugates for Prevention of Enteric Bacterial Diseases / John B. Robbins, Rachel Schneerson, Shousun C. Szu -- Ch. 53 Vaccines Against Gonococcal Infection / Timothy A. Mietzner, Myron S. Cohen -- Ch. 54 Vaccines Against Shigella Infections 843 i Escherichia coli- or Salmonella typhi-Expressing Shigella Antigens / Thomas Larry Hale, Malabi M. Venkatesan 843 ii Engineered Attenuated Mutants of Shigella as Live Oral Vaccines / Fernando Noriega, Samuel B. Formal, Karen L. Kotloff [et al.] -- Ch. 55 Vaccines Against Enterotoxigenic Escherichia coli Infections 865 i Oral Inactivated Vaccines Against Enterotoxigenic Escherichia coli / Ann-Mari L. Svennerholm, Christina Ahren, Marianne Jertborn 865 ii Live Oral Vaccines and Subunit (Purified Fimbriae and Toxin Subunit) Vaccines / Carol O. Tacket, Myron M. Levine -- Ch. 56 Vaccines Against Campylobacter jejuni / Daniel A. Scott, Shahida Baqar, Donald H. Burr [et al.] -- Ch. 57 Vaccines Against Lyme Disease / Robert Edelman -- Ch. 58 Vaccines Against Dental Caries Infection / Daniel J. Smith, Martin A. Taubman -- Ch. 59 Vaccines Against Klebsiella, Pseudomonas, and Septicemic E. coli Infections / Alan S. Cross, Stanley J. Cryz, Jr. -- Ch.60 Vaccines Against Escherichia coli and Proteus Urinary Tract Infections / Harry L. T. Mobley -- Ch.61 Vaccines Against Helicobacter pylori / Adrian Lee, Christopher Doidge -- Ch. 62 Vaccines for Staphylococcus aureus Infections / Ali I. Fattom, Robert B. Naso -- Ch. 63 Vaccines Against Malaria -- Ch. i Synthetic Peptide Vaccines Against the Sporozoite Stage of Plasmodium / Elizabeth H. Nardin, Ruth S. Nussenzweig -- Ch. ii Vaccines Designed to Induced Protective T-Cell Reponses Against Plasmodium-Infected Hepatocytes / John B. Sacci, Jr., Eileen D. Franke, Stephen L. Hoffman 1009 iii Spf66 Vaccine Against Asexual Erythrocytic Stages of P. |
